Medical Devices
-
Medical device industry says future MDUFA hikes unsustainable
Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for postmarket safety.
By Elise Reuter • Aug. 5, 2025 -
EU delays countermeasures to US tariffs by 6 months
The bloc has now paused implementation three times, with the latest moratorium coming after reaching a framework deal with the U.S.
By Philip Neuffer • Aug. 5, 2025 -
Explore the Trendline➔
Sara Silbiger via Getty ImagesTrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Philips BiPAP machine recall associated with 8 deaths
Philips sent updated instructions after disclosing problems last year with an alarm that can interrupt treatment for people with obstructive sleep apnea or respiratory insufficiency.
By Elise Reuter • Aug. 5, 2025 -
Alcon to acquire STAAR Surgical for about $1.5B
BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.
By Susan Kelly • Aug. 5, 2025 -
First Corcym aortic valve implanted via new robotic procedure
CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than transcatheter aortic valve replacement.
By Susan Kelly • Aug. 5, 2025 -
Heartflow prices IPO, aiming to net about $180M
The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 per share.
By Nick Paul Taylor • Aug. 4, 2025 -
Vicarious Surgical names Stephen From as next CEO
From, who joins the surgical robot developer from Aruna Bio, will take the reins from co-founder Adam Sachs on Aug. 7.
By Susan Kelly • Aug. 1, 2025 -
Trump tariffs
US, Mexico agree to extend USMCA-tariff pause
The two countries will continue to negotiate over a 90-day period during which imports from Mexico will avoid a planned 30% tariff from the Trump administration.
By Philip Neuffer • Aug. 1, 2025 -
News roundup
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared
Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA clearance for a robotically navigated electrophysiology mapping catheter.
By Susan Kelly • July 31, 2025 -
Dexcom raises sales expectations, discusses G8 plans
Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and over-the-counter devices to drive future growth.
By Elise Reuter • July 31, 2025 -
Cardiosense wins FDA clearance for wearable heart monitor
The device captures various types of heart data that could be used in AI models for cardiovascular parameters with the aim of lowering barriers to monitoring.
By Nick Paul Taylor • July 31, 2025 -
Dexcom CEO Kevin Sayer to step down
Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.
By Elise Reuter • Updated July 31, 2025 -
Earnings & Tariffs
GE HealthCare projects reduced tariff expense
Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger order growth.
By Susan Kelly • July 30, 2025 -
Earnings & Tariffs
Siemens Healthineers cuts tariff impact after trade talk breakthrough
The company predicted a full-year impact of 200 million to 250 million euros, down from its previous forecast of up to 300 million euros.
By Nick Paul Taylor • July 30, 2025 -
Earnings & Tariffs
Philips lowers expected tariff hit to 150M to 200M euros
The company previously forecast an up to 300 million euro tariff impact in 2025 before the U.S. struck agreements with China and the European Union.
By Elise Reuter • July 29, 2025 -
J&J’s Ethicon recalls stapler cartridges over issue linked to 1 death
The FDA said the device can lock, leading to adverse events including surgical delay, bleeding and death.
By Nick Paul Taylor • Updated July 29, 2025 -
Olympus, Revival Healthcare partner to start GI robotics firm
Olympus and Revival Healthcare Capital agreed to invest up to $458 million combined to co-found a company that will develop a robotic platform for gastrointestinal treatment.
By Susan Kelly • July 28, 2025 -
Trump tariffs
US, EU agree to lower tariffs in ‘framework’ deal
Most imports from the bloc would face a 15% tariff under the pact, U.S. President Donald Trump and European Commission President Ursula von der Leyen announced Sunday.
By Philip Neuffer • July 28, 2025 -
Sponsored by Native
Value creation through innovation and design
To lead in this era, medtech companies must expand how they innovate — combining scientific rigor with human connection, intuitive design, efficient operations and strategic clarity.
July 28, 2025 -
Trump tariffs
EU preps latest round of US tariff countermeasures
The European Commission plans to install duties of up to 30%, starting Aug. 7, if the bloc cannot reach a deal with the U.S. by the end of the month.
By Philip Neuffer • July 25, 2025 -
Edwards loses longtime TAVR leader Larry Wood
Wood, who helped build Edwards’ TAVR business, will become CEO of Procept BioRobotics. Edwards also raised its sales and earnings outlook for the full year.
By Susan Kelly • July 25, 2025 -
Edwards recalls arterial cannulas over exposed wires
Exposed wires could puncture the artery and cause bleeding, inadequate perfusion and hemolysis, the FDA said in its Class I recall notice.
By Nick Paul Taylor • July 25, 2025 -
Aidoc raises $150M for AI foundation model
The technology, called CARE, is expected to allow for faster development of AI models that can cover more health conditions.
By Elise Reuter • July 24, 2025 -
Medtronic receives Type 2 label expansion for MiniMed 780G in Europe
The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as 2.
By Elise Reuter • July 23, 2025 -
Earnings & Tariffs
Intuitive Surgical tempers tariff impact expectations
Executives also addressed Medicaid concerns and competition from third-party suppliers of remanufactured surgical instruments on an earnings call.
By Susan Kelly • July 23, 2025